Financial Performance - HY25 total revenue reached £12567 million, a 18% increase compared to HY24 at constant rates[32] - New Category revenue grew by 24% to £1689 million[32] - Adjusted profit from operations increased by 19% to £5435 million, adjusted for Canada[32] - Adjusted diluted earnings per share (EPS) increased by 17% to 1621 pence, adjusted for Canada[32] New Categories - Smokeless products represent 182% of Group revenue, an increase of 70bps[28] - New Category contribution margin increased by 28 percentage points to 106%[28] - Velo Plus experienced strong volume share gains, up 87 percentage points from November 2024 to May 2025[89] Regional Performance - The U S saw a return to revenue and profit growth, driven by combustibles recovery and Velo Plus momentum[30, 46] - In the U S , Velo revenue grew by 384%[46] - Combustibles revenue in the U S increased by 38%[46] - APMEA was impacted by combustibles fiscal and regulatory headwinds, with a revenue decrease of 48%[52] Strategic Initiatives - The company increased its share buy-back program to £11 billion for FY25[28, 30] - The company is targeting >£12 billion in productivity savings from 2023-2025[59] - The company is aiming to generate >£50 billion in free cash flow by the end of 2030[69]

Core Insights - Altria Group Inc. reported second-quarter 2025 results with both revenue and earnings exceeding expectations and showing year-over-year growth [1][2][11] Financial Performance - Adjusted earnings per share (EPS) for the second quarter were $1.44, an increase of 8.3% year over year, surpassing the Zacks Consensus Estimate of $1.37 [2][11] - Net revenues totaled $6,102 million, a decline of 1.7% year over year, primarily due to decreased revenues in the smokeable products segment, partially offset by growth in oral tobacco products [3][11] - Revenues net of excise taxes increased by 0.2% to $5,290 million, beating the consensus estimate of $5,190 million [3] Segment Performance - **Smokeable Products**: Net revenues fell 2.5% year over year to $5,357 million, driven by reduced shipment volumes, although higher pricing provided some offset [4][5] - Domestic cigarette shipment volumes decreased by 10.2%, attributed to industry decline and retail share losses, while cigar shipment volumes increased by 3.7% [5] - Adjusted operating companies' income (OCI) in this segment rose 4.2% to $2,947 million, with adjusted OCI margins growing by 2.9 percentage points to 64.5% [6] - **Oral Tobacco Products**: Net revenues increased by 5.9% to $753 million, mainly due to higher pricing, despite a decline in domestic shipment volumes by 1% [7][8] - Adjusted OCI in this segment grew by 10.9%, with adjusted OCI margins increasing by 3.1 percentage points to 68.7% [8] Shareholder Returns and Guidance - The company repurchased 4.7 million shares for $274 million in the second quarter, with $400 million remaining under its $1 billion share repurchase program [10] - Altria paid dividends totaling $1.7 billion in the second quarter [10] - The company narrowed its full-year 2025 adjusted EPS guidance to a range of $5.35 to $5.45, indicating a year-over-year growth of 3% to 5% [11][12]

Group 1 - Proactive provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [2] - The news team covers medium and small-cap markets, as well as blue-chip companies, commodities, and broader investment stories [3] - Proactive has bureaus and studios in key finance and investing hubs including London, New York, Toronto, Vancouver, Sydney, and Perth [2][3] Group 2 - The company is a forward-looking technology adopter, utilizing various technologies to enhance workflows [4] - Proactive employs automation and software tools, including generative AI, while ensuring all content is edited and authored by humans [5]

Core Insights - Altria reported revenue of $5.29 billion for the quarter ended June 2025, reflecting a 0.3% increase year-over-year and surpassing the Zacks Consensus Estimate of $5.19 billion by 1.93% [1] - The company's EPS for the quarter was $1.44, up from $1.31 in the same quarter last year, exceeding the consensus estimate of $1.37 by 5.11% [1] Revenue Breakdown - Smokeable Products generated revenues net of excise taxes of $4.57 billion, slightly above the estimated $4.43 billion, but down 0.4% from the previous year [4] - Oral tobacco products reported revenues net of excise taxes of $728 million, exceeding the estimated $701.72 million, marking a 6% increase year-over-year [4] - The segment "All Other/Financial Services" reported a net revenue of -$8 million, significantly below the estimated $14 million, representing a drastic year-over-year decline of 366.7% [4] Operating Income - Adjusted Operating Income (OCI) for Smokeable Products was $2.95 billion, surpassing the average estimate of $2.86 billion [4] - The Operating Income for Oral tobacco products was $498 million, exceeding the average estimate of $459.6 million [4] - The Operating Loss for "All Other/Financial Services" was reported at -$108 million, closely aligning with the average estimate of -$108.5 million [4] Stock Performance - Altria's shares have returned +2.1% over the past month, compared to a +3.4% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]

Financial Data and Key Metrics Changes - Adjusted diluted earnings per share increased by 8.3% to $1.44 in the second quarter and by 7.2% for the first half [19] - Adjusted operating companies income in the Smokable Products segment grew by 4.2% to $2.9 billion in the second quarter and by 3.5% to $5.5 billion in the first half [19] - Adjusted OCI margins expanded to 64.5% for both the second quarter and the first half [20] Business Line Data and Key Metrics Changes - In the Smokable Products segment, domestic cigarette volumes declined by 10.2% in the second quarter and 11.9% for the first half [20] - Oral nicotine pouches, particularly ON!, reported a shipment volume increase of 26.5% to 52.1 million cans in the second quarter [11] - Adjusted OCI for the Oral Tobacco Products segment grew by 10.9% in the second quarter and 5.5% in the first half [23] Market Data and Key Metrics Changes - The e-vapor category included over 20.5 million vapers, up by over 1.9 million year over year [14] - Disposable vapers increased by an estimated 2.7 million to approximately 14.4 million, representing over 60% of the e-vapor category [14] - Domestic cigarette volumes at the industry level declined by an estimated 8.5% in the second quarter [20] Company Strategy and Development Direction - The company aims to shape a fully regulated industry and provide expanded product choices for adult nicotine consumers [8] - Continued focus on driving trial, building long-term equity, and increasing profitability in the ON! brand [12] - The company is actively exploring potential next steps regarding the nJoy e-vapor product line, including an appeal against patent disputes [13] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the strong performance of operating companies despite challenging market conditions [18] - The macroeconomic environment remains dynamic, with inflation and consumer confidence being key factors to monitor [32] - The company raised the lower end of its 2025 guidance range, expecting adjusted diluted EPS in the range of $5.35 to $5.45 [25] Other Important Information - The company returned over $4 billion to shareholders through dividends and share repurchases in the first half of the year [8] - The total debt to EBITDA ratio as of June 30 was 2.0 times, in line with the target [26] - The company is advocating for more coordinated actions against illicit e-vapor products to clean up the marketplace [16] Q&A Session Summary Question: Insights on the raised guidance range and consumer environment - Management highlighted the dynamic market and the need to monitor adult tobacco consumer behaviors due to inflationary pressures [31] Question: Update on nJoy e-vapor product development - Management confirmed that product development for the nJoy ACE device is progressing, with plans to file for FDA approval [35] Question: Long-term EPS growth outlook - Management remains confident in achieving mid-single-digit EPS growth through FY 2028, despite economic strains on consumers [44] Question: Strategy for the Basic brand - The company is using targeted analytics to maintain consumer loyalty and expand the Basic brand's presence in discount segments [49] Question: Impact of illicit vape crackdowns - Management noted that while enforcement actions are increasing, it is too early to determine their overall impact on the market [58] Question: Tariff impacts on business - Tariffs have had some impact on costs, particularly in supply chain materials, but are not viewed as material to overall business performance [98]

Financial Data and Key Metrics Changes - Adjusted diluted earnings per share increased by 8.3% to $1.44 in Q2 2025 and by 7.2% for the first half, driven by robust adjusted operating companies income growth and share repurchases [19][25] - Adjusted operating companies income for the Smokable Products segment grew by 4.2% to $2.9 billion in Q2 and by 3.5% to $5.5 billion in the first half [19][20] - Adjusted OCI margins expanded to 64.5% for both Q2 and the first half [20] Business Line Data and Key Metrics Changes - Oral nicotine pouches, particularly ON!, were the primary growth driver, with reported shipment volume increasing by 26.5% to 52.1 million cans year-over-year [9][23] - Domestic cigarette volumes in the Smokable Products segment declined by 10.2% in Q2 and 11.9% for the first half, with adjusted estimates showing declines of approximately 10.5% [20][21] - The Oral Tobacco Products segment saw adjusted OCI grow by 10.9% in Q2, primarily driven by ON!'s strong performance [23] Market Data and Key Metrics Changes - The e-vapor category included over 20.5 million vapers, up by 1.9 million year-over-year, with disposable vapers increasing to approximately 14.4 million [14][15] - The flavored disposable market continues to drive e-vapor category growth, representing over 60% of the category [15][16] Company Strategy and Development Direction - The company is focused on shaping a fully regulated industry and expanding product choices for adult nicotine consumers, while also advocating for enforcement against unregulated products [7][14] - The strategy includes targeted launches and promotions for the Basic brand to retain consumers in the portfolio while addressing macroeconomic pressures [21][49] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the strong performance of operating companies despite challenging market conditions and inflationary pressures [18][32] - The company raised the lower end of its 2025 guidance range, expecting adjusted diluted EPS to be in the range of $5.35 to $5.45, reflecting a growth rate of 3% to 5% from 2024 [25][26] Other Important Information - The company returned significant value to shareholders, paying approximately $3.5 billion in dividends and repurchasing 10.4 million shares for $600 million in the first half of the year [26][27] - The total debt to EBITDA ratio as of June 30 was 2.0 times, in line with the target [27] Q&A Session Summary Question: Discussion on the raised guidance range and expectations for the second half - Management acknowledged the strong first half results and the dynamic market conditions, emphasizing the need to monitor consumer behavior amid inflation [30][32] Question: Update on nJoy e-vapor product development - Management confirmed that product development for the new nJoy device is progressing, with plans to file for FDA approval once ready [34][36] Question: Long-term EPS growth outlook - Management remains confident in achieving mid-single-digit EPS growth through FY 2028, despite current economic strains on consumers [43][44] Question: Strategy for the Basic brand and discount share - The company is strategically repositioning Basic as a discount brand while using data analytics to target consumers effectively [49][50] Question: Impact of enforcement on illicit vapes and cigarette volumes - Management noted that while enforcement actions are increasing, it is too early to determine their full impact on the market [55][58] Question: Clarification on tariff impacts - Management indicated that while tariffs have affected costs, they do not view them as material to overall business performance [96][97]

Core Insights - Altria reported quarterly earnings of $1.44 per share, exceeding the Zacks Consensus Estimate of $1.37 per share, and up from $1.31 per share a year ago [1][2] - The company achieved revenues of $5.29 billion for the quarter, surpassing the Zacks Consensus Estimate by 1.93%, and slightly up from $5.28 billion year-over-year [3] - Altria's stock has increased approximately 13.5% year-to-date, outperforming the S&P 500's gain of 8.3% [4] Earnings Performance - The earnings surprise for the recent quarter was +5.11%, following a previous surprise of +5.13% in the prior quarter [2] - Over the last four quarters, Altria has consistently surpassed consensus EPS estimates [2][3] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $1.43 on revenues of $5.29 billion, and for the current fiscal year, it is $5.37 on revenues of $20.14 billion [8] - The estimate revisions trend for Altria was mixed prior to the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [7] Industry Context - The Tobacco industry, to which Altria belongs, is currently ranked in the top 37% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [9] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [6]

Altria's Second-Quarter and First-Half 2025 Earnings Conference Call July 30, 2025 1 | ALCS | Q2 2025 | 7.30.25 | For Investor Purposes ONLY Safe Harbor Statement Statements, including earnings guidance, in this presentation that are not reported financial results or other historical information are "forward-looking statements" within the meaning of Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on current plans, estimates and expectations, and are not guarantees ...

Core Viewpoint - 22nd Century Group, Inc. is the only tobacco company authorized by the FDA to produce reduced nicotine content combustible cigarettes, specifically their VLN products, which align with the proposed FDA standard for nicotine yield [1][4]. Group 1: Public Health Impact - Smoking in the U.S. results in over 480,000 deaths and costs more than $600 billion annually, significantly reducing life expectancy by 10 years [2]. - The proposed FDA standard aims to limit nicotine in combusted tobacco products to less than 0.7mg per gram, addressing public health issues related to nicotine addiction [2][9]. Group 2: Industry Position and Product Offering - 22nd Century Group's VLN products contain 95% less nicotine than traditional cigarettes, providing smokers with a familiar alternative that allows for better control over nicotine consumption [6][7]. - The company has developed proprietary non-GMO reduced nicotine tobacco blends through patented technologies, ensuring they hold a unique position in the market with the only low nicotine combustible cigarette in the U.S. and key international markets [7]. Group 3: Support from Medical Community - The American Academy of Family Physicians, representing over 128,300 family physicians, supports the FDA's proposed nicotine yield standard, emphasizing its importance in combating tobacco dependence [3][9].

Core Insights - Altria is expected to announce earnings on July 30, 2025, with analysts projecting earnings of $1.38 per share and revenues of $5.19 billion, compared to $1.31 per share and $5.28 billion in the same quarter last year [3][4]. Group 1: Historical Performance - Over the past five years, Altria's stock has shown a positive one-day return in 53% of cases following earnings announcements, with a median one-day increase of 1.9% and a maximum increase of 7.8% [3][7]. - In the last three years, the percentage of positive one-day returns increased to 55%, with the median of positive returns at 1.9% and negative returns at -2.1% [7]. Group 2: Financial Metrics - Altria has a current market capitalization of $101 billion, generating $20 billion in revenue over the past twelve months, with $12 billion in operating profits and a net income of $10 billion, indicating strong operational profitability [4]. Group 3: Trading Strategies - Traders may consider pre-earnings positioning based on historical probabilities and evaluate immediate and mid-term stock reactions post-earnings to inform trading decisions [6]. - Correlation between short-term and medium-term returns can be analyzed to identify suitable trading strategies, particularly if the 1D and 5D returns show high correlation [8].